Status:
RECRUITING
Sleep Quality Evolution: Dreem Under CPAP
Lead Sponsor:
University Hospital, Grenoble
Collaborating Sponsors:
Dreem
AGIR à Dom
Conditions:
Sleep Apnea
Obstructive Sleep Apnea
Eligibility:
All Genders
30-65 years
Phase:
NA
Brief Summary
Continuous positive airway pressure (CPAP) has a caricatural effect in reducing nocturnal respiratory abnormalities and improving the micro-and macrostructure of sleep. Studies characterizing the impr...
Detailed Description
This study aims to evaluate the quality of sleep, principally the deep slow-wave sleep (sleep stage N3) before and after the initiation of continuous positive airway pressure (CPAP) treatment. 70 new...
Eligibility Criteria
Inclusion
- Patients newly diagnosed with OSA requiring CPAP treatment
- Patients able to use a mobile application on a smartphone or tablet
- Patients with access to a wi-fi internet connection at home
- Patients agreeing to remote monitoring of CPAP compliance data by the home care provider
- Patients who have signed consent to participate in the study
- Subjects affiliated to a social security
Exclusion
- Patients already treated for OSA
- Patients treated with a sleep aid (sleeping medications)
- Patients with severe chronic obstructive or restrictive lung disease with or without oxygen
- Patients with unstable cardiovascular disease or severe heart failure requiring hospitalization within the last three months or meeting New York Heart Association criteria, Class III or IV disease
- Subjects listed in articles L1121-5 to L1121-8: pregnant women, feeding and parturients, subjects deprived of liberty by judicial or administrative decision, persons under legal protection
- Persons in a period of exclusion from another study or ongoing participation in a drug study
- Subjects likely, at the investigator's discretion, to be uncooperative or noncompliant with the obligations inherent to participation in the study
Key Trial Info
Start Date :
October 3 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 3 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05197855
Start Date
October 3 2022
End Date
December 3 2025
Last Update
December 27 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Grenoble Alpes University Hospital
Grenoble, France